MAM
IMI

Martingale Asset Management’s Intermolecular, Inc. IMI Stock Holding History

Martingale Asset Management’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-12,000
Closed -$88K – 1068
2013
Q2 		$88K Buy
+12,000
New +$102K ﹤0.01% 951

Other funds holding IMI

PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KSC
Kendall Square Capital San Francisco, California $4.92M AUM 2.25% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Martingale Asset Management's IMI Position: Q3 2013 in Review

Martingale Asset Management sold out of Intermolecular, Inc. (IMI) in Q3 2013, closing a stake of 12,000 shares — an estimated $88K sold.

Martingale Asset Management first reported a position in IMI in Q2 2013 and held it in 1 quarter. The position peaked at $88K in Q2 2013. 62 funds tracked by Wall St. Rank hold IMI as of Q3 2013.

  • Martingale Asset Management reported no remaining Intermolecular, Inc. position as of Q3 2013 after selling out during the quarter.
  • Martingale Asset Management sold 12,000 Intermolecular, Inc. shares in Q3 2013, an estimated $88K.
  • Martingale Asset Management first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 1 quarter.
  • Martingale Asset Management's Intermolecular, Inc. position peaked at $88K in Q2 2013.
  • 62 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2013.

Based on Martingale Asset Management's 13F filing for Q3 2013, filed 13 Nov 2013.